Viewing Study NCT01512693


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-04 @ 5:56 PM
Study NCT ID: NCT01512693
Status: COMPLETED
Last Update Posted: 2018-08-29
First Post: 2012-01-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-02-23
Start Date Type: ACTUAL
Primary Completion Date: 2012-04-24
Primary Completion Date Type: ACTUAL
Completion Date: 2012-04-24
Completion Date Type: ACTUAL
First Submit Date: 2012-01-13
First Submit QC Date: None
Study First Post Date: 2012-01-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-06-12
Results First Submit QC Date: None
Results First Post Date: 2017-10-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-30
Last Update Post Date: 2018-08-29
Last Update Post Date Type: ACTUAL